1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Biomlogic Inc. has 1 pending office action. Jones-Foster, Erica Nicole is the examiner for this matter. As the busiest examiner, Jones-Foster, Erica Nicole holds the 1 pending action. This concentrated prosecution requires a direct focus on the specific requirements and feedback of the assigned examiner. The absence of other pending matters simplifies the procedural landscape for the company.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JONES-FOSTER, ERICA NICOLE | 1 | 49.4% | +44.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18866485 | SUPEROXIDE DISMUTASE AND USES THEREOF FOR PREVENTING OR TREATING MUCOSITIS | JONES-FOSTER, ERICA NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18866485 | SUPEROXIDE DISMUTASE AND USES THEREOF FOR PREVENTING OR TREATING MUCOSITIS | JONES-FOSTER, ERICA NICOLE | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18866485 | SUPEROXIDE DISMUTASE AND USES THEREOF FOR PREVENTING OR TREATING MUCOSITIS | JONES-FOSTER, ERICA NICOLE | — | §101§102§103§112 | Non-Final OA | — | Pending | Feb 14, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiomlogic Inc. has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Erica Nicole Jones-Foster has the most, with 1 of Biomlogic Inc.'s pending office actions.
